
HOB Biotech Group Corp.,Ltd
SSE:688656.SS
126.5 (CNY) • At close June 13, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
---|---|---|---|---|---|---|---|---|---|
Assets: | |||||||||
Current Assets: | |||||||||
Cash & Cash Equivalents
| 121.625 | 163.466 | 153.804 | 449.855 | 58.815 | 90.762 | 66.522 | 14.02 | 12.999 |
Short Term Investments
| 0 | 427.036 | 135.228 | 5.011 | 0 | -3.125 | -0.43 | -0.356 | -1.196 |
Cash and Short Term Investments
| 121.625 | 163.466 | 289.031 | 454.866 | 58.815 | 90.762 | 66.522 | 14.02 | 12.999 |
Net Receivables
| 50.973 | 45.442 | 32.378 | 37.484 | 29.899 | 20.324 | 22.108 | 11.368 | 6.155 |
Inventory
| 111.221 | 111.217 | 87.802 | 68.205 | 61.948 | 59.631 | 49.162 | 38.735 | 30.013 |
Other Current Assets
| 8.3 | 8.089 | 13.773 | 18.325 | 13.392 | 8.118 | 3.598 | 8.11 | 4.398 |
Total Current Assets
| 292.119 | 328.214 | 422.984 | 569.971 | 158.654 | 176.489 | 140.385 | 68.694 | 52.73 |
Non-Current Assets: | |||||||||
Property, Plant & Equipment, Net
| 705.707 | 578.682 | 485.272 | 260.008 | 119.966 | 82.082 | 72.804 | 58.1 | 49.134 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 10.081 | 11.859 | 12.587 | 12.169 | 11.289 | 11.739 | 0.535 | 0.616 | 0.6 |
Goodwill and Intangible Assets
| 10.081 | 11.859 | 12.587 | 12.169 | 11.289 | 11.739 | 0.535 | 0.616 | 0.6 |
Long Term Investments
| 0 | 0 | 0.098 | 10.892 | 3.455 | 8.822 | 5.896 | 13.789 | 21.285 |
Tax Assets
| 4.126 | 2.473 | 1.845 | 1.628 | 0.965 | 2.603 | 3.017 | 1.159 | 0.174 |
Other Non-Current Assets
| 20.771 | 28.029 | 21.772 | 9.25 | 2.081 | 1.443 | 2.587 | 1.867 | 0.727 |
Total Non-Current Assets
| 740.686 | 621.043 | 521.575 | 293.948 | 137.756 | 106.688 | 84.839 | 75.53 | 71.92 |
Total Assets
| 1,032.805 | 949.257 | 944.559 | 863.919 | 296.41 | 283.177 | 225.224 | 144.224 | 124.65 |
Liabilities & Equity: | |||||||||
Current Liabilities: | |||||||||
Account Payables
| 44.587 | 23.909 | 48.33 | 11.125 | 7.519 | 5.861 | 2.925 | 4.083 | 6.488 |
Short Term Debt
| 105.066 | 50.024 | 50.012 | 20.017 | 20.019 | 45.049 | 13 | 30 | 29.645 |
Tax Payables
| 9.138 | 9.371 | 4.876 | 6.45 | 3.293 | 3.076 | 3.254 | 2.213 | 1.834 |
Deferred Revenue
| 0 | 0 | 13.335 | 44.391 | 30.843 | 66.777 | 3.254 | 15.605 | 14.567 |
Other Current Liabilities
| 51.149 | 52.447 | 49.498 | 48.575 | 32.397 | 71.181 | 58.421 | 16.707 | 16.789 |
Total Current Liabilities
| 209.941 | 135.752 | 152.717 | 86.167 | 63.227 | 122.893 | 77.6 | 53.003 | 54.756 |
Non-Current Liabilities: | |||||||||
Long Term Debt
| 9.526 | 1.032 | 9.743 | 5.347 | 32.189 | 5.025 | 6.026 | 6.983 | 7.892 |
Deferred Revenue Non-Current
| 1.201 | 1.74 | 2.492 | 2.402 | 2.813 | 3.351 | 3.761 | 4.171 | 4.567 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0.034 | 0.002 | 23.983 | 0 | 0 | 0 | 0.205 |
Other Non-Current Liabilities
| 0 | 0 | 2.492 | 2.404 | 2.813 | 3.351 | 0.957 | 1.039 | 0.519 |
Total Non-Current Liabilities
| 10.727 | 2.772 | 12.269 | 7.751 | 26.796 | 10.648 | 14.504 | 12.193 | 13.183 |
Total Liabilities
| 220.667 | 138.524 | 164.987 | 93.918 | 90.023 | 133.541 | 92.105 | 65.197 | 67.939 |
Equity: | |||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 63.058 | 63.058 | 63.058 | 63.058 | 47.294 | 47.294 | 47.294 | 45 | 12.869 |
Retained Earnings
| 174.028 | 162.127 | 133.929 | 131.313 | 72.949 | 23.077 | 12.715 | 16.381 | 17.64 |
Accumulated Other Comprehensive Income/Loss
| 0 | 0 | 33.23 | 26.277 | 34.858 | 79.257 | 73.11 | 17.646 | 0.955 |
Other Total Stockholders Equity
| 575.051 | 585.548 | 582.584 | 575.631 | 86.243 | 79.265 | 73.11 | 17.646 | 25.247 |
Total Shareholders Equity
| 812.137 | 810.733 | 779.572 | 770.002 | 206.387 | 149.636 | 133.119 | 79.027 | 56.711 |
Total Equity
| 812.137 | 810.733 | 779.572 | 770.002 | 206.387 | 149.636 | 133.119 | 79.027 | 56.711 |
Total Liabilities & Shareholders Equity
| 1,032.805 | 949.257 | 944.559 | 863.919 | 296.41 | 283.177 | 225.224 | 144.224 | 124.65 |